The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://hassanzbxd111584.eveowiki.com/2010793/glp_3_receptor_agonists_retatrutide_trizepatide